SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-218109
Filing Date
2022-08-11
Accepted
2022-08-11 09:21:56
Documents
17
Period of Report
2022-08-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d399265d8k.htm   iXBRL 8-K 47012
2 EX-4.1 d399265dex41.htm EX-4.1 112186
3 EX-99.1 d399265dex991.htm EX-99.1 12154
4 EX-99.2 d399265dex992.htm EX-99.2 77040
8 GRAPHIC g399265g0811114729572.jpg GRAPHIC 1869
9 GRAPHIC g399265g0811115443752.jpg GRAPHIC 35659
  Complete submission text file 0001193125-22-218109.txt   481837

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cinc-20220810.xsd EX-101.SCH 2842
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cinc-20220810_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cinc-20220810_pre.xml EX-101.PRE 11698
11 EXTRACTED XBRL INSTANCE DOCUMENT d399265d8k_htm.xml XML 3460
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 221154039
SIC: 2834 Pharmaceutical Preparations